Found 337 articles for: "eczema"
Usage of Topical Calcineurin Inhibitors in the Medicare Population from 2013 to 2018
August 2022 | Volume 21 | Issue 8 | Editorials | 912 | Copyright © August 2022
Topical calcineurin inhibitors are a family of drugs that have been touted for having high efficacy without the risks of cutaneous atrophy and systemic absorption seen with topical corticosteroids. Th...
Read MoreAdvances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream
June 2022 | Volume 21 | Issue 6 | Original Article | 582 | Copyright © June 2022
Purpose: Acne vulgaris is very common among adolescents and young adults. It is important for clinicians who provide care to these patients to have a plan of action for assessing and ...
Read MoreThe Use of Bakuchiol in Dermatology: A Review of In Vitro and In Vivo Evidence
June 2022 | Volume 21 | Issue 6 | Original Article | 624 | Copyright © June 2022
The plant Psoralea corylfolia contains compounds such as psoralens that are useful for the treatment of psoriasis and vitiligo, and the plant is used in Chinese and Indian traditional medicin...
Read MoreMohs Micrographic Surgery in Skin of Color
May 2022 | Volume 21 | Issue 5 | Features | 536 | Copyright © May 2022
The United States population is becoming increasingly diverse. Data show increased utilization of Mohs micrographic surgery (MMS) in people of color. Though the incidence of skin cancer in skin of col...
Read MoreCase Series of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Nivolumab and Nivolumab/ Ipilimumab Combination Therapy in Metastatic Melanoma
May 2022 | Volume 21 | Issue 5 | Case Reports | 529 | Copyright © May 2022
Nivolumab (anti PD-1 antibody) and ipilimumab (anti CTLA-4 antibody) are immune checkpoint inhibitors (ICI) that effectively stimulate the native T cell response and lead to an antitumor response. The...
Read MoreInsights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes
May 2022 | Volume 21 | Issue 5 | Original Article | 462 | Copyright © May 2022
Background: Research on the role of race and ethnicity in the pathophysiology of atopic dermatitis (AD) is limited. Variations in the epidemiology, clinical presentation, and disease ...
Read MoreAtopic Dermatitis and the Medications Used for its Management: Impact on Ocular Health
May 2022 | Volume 21 | Issue 5 | Case Reports | 523 | Copyright © May 2022
Atopic Dermatitis (AD) is one of the most common inflammatory skin conditions. AD is generally characterized by eczematous and pruritic skin lesions, although it can present differently between indivi...
Read MoreEvaluation of Cannabis and Cannabinoid Product Use, Knowledge, and Attitudes in the Eczema Community
April 2022 | Volume 21 | Issue 4 | Original Article | 413 | Copyright © April 2022
Background: Data to date supports the potential for targeting the cutaneous endocannabinoid system to treat eczematous dermatoses. However, our understanding of patient knowledge and ...
Read MoreGetting to the Core of Contemporary Therapies for Post-Inflammatory Hyperpigmentation
March 2022 | Volume 21 | Issue 3 | Original Article | 276 | Copyright © March 2022
Post-inflammatory hyperpigmentation (PIH) is a typical complication of inflammatory dermatoses that more frequently and severely affects people with darker skin. External insults to the skin, such as ...
Read MorePustular Psoriasis Appearing Induced by Dupilumab Therapy in a Patient With Atopic Dermatitis
March 2022 | Volume 21 | Issue 3 | Case Reports | 311 | Copyright © March 2022
Dupilumab inhibits T-helper 2 (Th2)-driven inflammation cascade by blocking interleukin-4 (IL-4) and IL-13 signaling, which has been recognized to play a crucial role in the pathogenesis of atopic der...
Read MoreAnalysis of Reddit Reveals Dupilumab Questions Among Atopic Dermatitis Patients
March 2022 | Volume 21 | Issue 3 | Original Article | 292 | Copyright © March 2022
Background: Atopic dermatitis patients are turning to social media to seek guidance and source medical information. Reddit, the seventh most visited website in the US, contains the po...
Read MoreArtificial Intelligence in the Evaluation of Telemedicine Dermatology Patients
February 2022 | Volume 21 | Issue 2 | Original Article | 191 | Copyright © February 2022
Background: Background: Early detection of malignant skin lesions reduces morbidity. There is increased need for a telemedicine triage tool to prioritize patients who require in-perso...
Read MoreThe Heterogeneity of Atopic Dermatitis
February 2022 | Volume 21 | Issue 2 | Original Article | 172 | Copyright © February 2022
Background: Recent advances were made in characterizing the clinical heterogeneity of atopic dermatitis (AD).
Objective: To review the clinical domains contribu...
Read MoreAlteration to the Skin Ceramide Profile Following Broad-Spectrum UV Exposure
January 2022 | Volume 21 | Issue 1 | Original Article | 77 | Copyright © January 2022
The epidermal stratum corneum (SC) lipid matrix, principally consisting of an equimolar ratio of ceramides, free fatty acids, and cholesterol, plays a crucial role in maintaining proper skin ...
Read MoreConsumer Perspectives on and Utilization of Medical Cannabis to Treat Dermatologic Conditions
January 2022 | Volume 21 | Issue 1 | Original Article | 31 | Copyright © January 2022
Background: Access to medical cannabis products (MCPs) has rapidly increased though literature on consumer behaviors and attitudes with regards to dermatologic use is limited.
<...
Read MoreTreatment of Alopecia in Children
January 2022 | Volume 21 | Issue 1 | Original Article | 49 | Copyright © January 2022
Alopecia or hair loss in children is an important and often challenging problem to diagnose and treat. Early diagnosis and treatment is the key because hair loss in children has a significant physical...
Read MoreTopical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis
December 2021 | Volume 20 | Issue 12 | Original Article | 1323 | Copyright © December 2021
Atopic dermatitis (AD) is a chronic skin condition affecting an increasing number of children and adults whose quality of life is impacted by chronic itch and pain. It is characterized by an altered e...
Read MorePatient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis
November 2021 | Volume 20 | Issue 11 | Original Article | 1222 | Copyright © November 2021
Background: Atopic dermatitis (AD) is a common, chronic, relapsing, inflammatory skin disease causing a variety of dermatologic signs and symptoms, affecting patient’s quality o...
Read MoreThe Importance of Skincare for Neonates and Infants: An Algorithm
November 2021 | Volume 20 | Issue 11 | Original Article | 1195 | Copyright © November 2021
Background: The skin of neonates and infants undergoes a maturation process from birth and is susceptible to barrier disruption. The current algorithm follows a US-based consensus pap...
Read MoreTherapeutic Approaches and Special Considerations for Treating Molluscum Contagiosum
November 2021 | Volume 20 | Issue 11 | Original Article | 1185 | Copyright © November 2021
Molluscum contagiosum (molluscum) is a common skin condition, especially in children, yet treatment approaches by US health care practitioners vary widely. A dearth of clinical data from large, well-c...
Read More